Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

224 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Risk factors for severe hearing loss in Susac syndrome: A national cohort study.
Peyre M, Mageau A, Henry Feugeas MC, Doan S, Halimi C, Klein I, Goulenok T, François C, Chauveheid MP, Papo T, Sacré K; French Susac Study Group. Peyre M, et al. Among authors: doan s. Eur J Neurol. 2024 May;31(5):e16211. doi: 10.1111/ene.16211. Epub 2024 Jan 18. Eur J Neurol. 2024. PMID: 38235955
Multicenter prospective observational study of dupilumab-induced ocular events in atopic dermatitis patients.
Costedoat I, Wallaert M, Gaultier A, Vasseur R, Vanhaecke C, Viguier M, Cordelette C, Denoyer A, Ferrier le Bouëdec MC, Coutu A, Lamiaux M, Tran THC, Lacour JP, Elmaleh V, Tetart F, Gueudry J, Tauber M, Giordano-Labadie F, Cassagne M, Nosbaum A, Ouilhon C, Jachiet M, Tadayoni R, Dezoteux F, Staumont-Salle D, Bouleau J, Labalette P, Doan S, Soria A, Mortemousque B, Seneschal J, Barbarot S; FRench Atopic DErmatitis Network from the Groupe de Recherche sur l'Eczema Atopique (GREAT), France. Costedoat I, et al. Among authors: doan s. J Eur Acad Dermatol Venereol. 2023 May;37(5):1056-1063. doi: 10.1111/jdv.18932. Epub 2023 Feb 16. J Eur Acad Dermatol Venereol. 2023. PMID: 36732052
Lichen planus pemphigoides with predominant mucous membrane involvement: a series of 12 patients and a literature review.
Combemale L, Bohelay G, Sitbon IY, Ahouach B, Alexandre M, Martin A, Pascal F, Soued I, Doan S, Morin F, Grootenboer-Mignot S, Caux F, Prost-Squarcioni C, Le Roux-Villet C. Combemale L, et al. Among authors: doan s. Front Immunol. 2024 Apr 15;15:1243566. doi: 10.3389/fimmu.2024.1243566. eCollection 2024. Front Immunol. 2024. PMID: 38686381 Free PMC article.
NOVATIVE: A Phase II/III, Multicenter, Double-masked, Randomized Study of Cyclosporine A 0.05% and 0.1% Ophthalmic Cationic Emulsion Versus Vehicle in Patients with Vernal Keratoconjunctivitis.
Leonardi A, Pisella PJ, Benítez-Del-Castillo JM, Amrane M, Ismail D, Doan S, Bremond-Gignac D. Leonardi A, et al. Among authors: doan s. Clin Ther. 2023 Dec;45(12):1284-1288. doi: 10.1016/j.clinthera.2023.09.022. Epub 2023 Oct 21. Clin Ther. 2023. PMID: 37872059 Clinical Trial.
Omalizumab for severe allergic keratoconjunctivitis: A case series.
Mercier M, Doan S, Elaouane I, Chelly Z, Bourgoin-Heck M, Lambert N, Cottel N, Taillé C, Wanin S. Mercier M, et al. Among authors: doan s. J Allergy Clin Immunol Pract. 2023 Nov;11(11):3528-3530. doi: 10.1016/j.jaip.2023.07.016. Epub 2023 Jul 22. J Allergy Clin Immunol Pract. 2023. PMID: 37482081 No abstract available.
224 results